Reverting immune suppressionto elicit brain metastasis control

About us*

The RISEbrain consortium brings together the highly complementary expertise of 6 teams with inter-sectorial (basic and clinical) and interdisciplinary focus (life sciences, computational sciences, engineering) to tackle the growing societal challenge posed by brain metastases.

Partners*

RISEbrain brings together 6 partners with diverse backgrounds and expertise. Learn more about our team on our website.

Positions available*

We currently have job openings available! If you are interested check out our website for more information on how to apply.

Consortium achievements*

At RISEBrain, each laboratory has achieved significant scientific achievements in their respective fields of study. Visit our website to learn more about our achievements and ongoing research.

Updating cancer research with patient-focused networks

Trends in Cancer

Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanoma

Journal for Immunotherapy of Cancer

Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer

J Immunother Cancer

TIMP1 mediates astrocyte-dependent local immunosuppression in brain metastasis acting on infiltrating CD8+ T cells

Cancer Discovery

Tackling the focal shift effect for metalenses

Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism. 

Monteiro, Miarka et al.
Nature Medicine

News & Outreach*

Our RISEbrain partners have been published and featured in top media outlets and conferences. Learn more on our website.

23/11/2024

News

Ricerca identifica meccanismo che sviluppa metastasi cerebrali

23/11/2024

News

Ecco il meccanismo che permette ai tumori di proliferare: la scoperta di Città della Salute e Università di Torino sulle metastasi cerebrali

01/01/2025

News

AECC destaca una nueva estrategia para tratar metástasis cerebrales en modelos animales y pacientes

News

RENACER Network Presentation

11/07/2024

Interview

Manuel Valiente, ‘Making your research translatable’

The European Association for Cancer Research (EACR)

24/01/2024

News

Living Biobank Of Brain Metastasis Samples Enabling ‘Personalized Medicine 2.0’

Clinical Research News